July 2019 newsletter
The importance of understanding protein-protein and protein-ligand interactions in immuno-oncology Immuno-oncology represents a new paradigm in the fight against cancer and ...
By combining the strengths of Blaze for ligand-based work with Lead Finder for docking, CDS now has the most comprehensive virtual screening capabilities available anywhere in the industry.
See a selection of case studies that represent our larger body of work with selections taken from recent, most popular and historical studies.
We actively support academic research through flexible licensing terms. Licenses have been created specifically to facilitate internal academic research within a university.
See the presentations from our Symposia on Innovative Software for the Discovery and Design of Novel Compounds, Bangalore and Pune, India.
Our 2017 User Group Meeting will take place in Cambridge, UK on June 29-30, 2017. Note this date in your diary – further details will be announced soon. In addition to the scientific meeting, we will celebrate 15 years since Andy Vinter founded Cresset.
The following publications have recently cited Cresset technology. View these and other citations.